https://www.selleckchem.com/pr....oducts/3-deazaadenos
Greater MRT of DCP-C (OR 1.044; p = 0.002) and more frequent intravitreal injections (OR 1.803; p less then 0.001) were associated with a higher risk of relapsing ME. DCP-C may contribute to the anatomical stability of chronic BRVO and simultaneously be the source of ME.We compared accuracy for breast cancer (BC) risk stratification of a new fully automated system (DenSeeMammo-DSM) for breast density (BD) assessment to a non-inferiority threshold based on radiologists' visual assessment. Pooled analysis was perf
Like
Comment
Share
